Marshall Wace North America L.P. - COLLEGIUM PHARMACEUTICAL INC ownership

COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 142 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q3 2020. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of COLLEGIUM PHARMACEUTICAL INC
ValueSharesWeighting
Q3 2020$283,000
-84.3%
13,614
-84.4%
0.00%
-77.8%
Q4 2019$1,800,000
+48.6%
87,455
-17.1%
0.01%
+28.6%
Q3 2019$1,211,000
-15.4%
105,491
-3.0%
0.01%
-22.2%
Q2 2019$1,431,000108,756
+388314.3%
0.01%
Q1 2019$0
-100.0%
28
-99.8%
0.00%
-100.0%
Q2 2018$345,00014,4470.00%
Other shareholders
COLLEGIUM PHARMACEUTICAL INC shareholders Q3 2020
NameSharesValueWeighting ↓
Tejara Capital Ltd 289,803$6,477,0973.67%
Tamarack Advisers, LP 185,000$4,134,7502.68%
Rubric Capital Management LP 3,175,000$70,961,2502.66%
Eventide Asset Management 2,631,334$58,810,3151.06%
Camber Capital Management LP 1,050,000$23,4680.77%
EMERALD MUTUAL FUND ADVISERS TRUST 559,480$12,504,3780.76%
EMERALD ADVISERS, LLC 690,487$15,432,3800.75%
Values First Advisors, Inc. 43,507$972,3740.63%
AlphaCentric Advisors LLC 49,500$1,106,3250.63%
SummerHaven Investment Management, LLC 33,666$752,4350.55%
View complete list of COLLEGIUM PHARMACEUTICAL INC shareholders